AU7361900A - Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins - Google Patents

Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins

Info

Publication number
AU7361900A
AU7361900A AU73619/00A AU7361900A AU7361900A AU 7361900 A AU7361900 A AU 7361900A AU 73619/00 A AU73619/00 A AU 73619/00A AU 7361900 A AU7361900 A AU 7361900A AU 7361900 A AU7361900 A AU 7361900A
Authority
AU
Australia
Prior art keywords
prevention
compositions
treatment
methods
heat shock
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73619/00A
Inventor
Rajiv Y. Chandawarkar
Pramod K Srivastava
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fordham University
Original Assignee
Fordham University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fordham University filed Critical Fordham University
Publication of AU7361900A publication Critical patent/AU7361900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6043—Heat shock proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU73619/00A 1999-09-10 2000-09-08 Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins Abandoned AU7361900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39365299A 1999-09-10 1999-09-10
US09393652 1999-09-10
PCT/US2000/024711 WO2001017554A1 (en) 1999-09-10 2000-09-08 Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins

Publications (1)

Publication Number Publication Date
AU7361900A true AU7361900A (en) 2001-04-10

Family

ID=23555669

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73619/00A Abandoned AU7361900A (en) 1999-09-10 2000-09-08 Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins

Country Status (4)

Country Link
EP (1) EP1218030A4 (en)
AU (1) AU7361900A (en)
CA (1) CA2383213A1 (en)
WO (1) WO2001017554A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003504074A (en) 1999-07-08 2003-02-04 ストレスゲン バイオテクノロジーズ コーポレイション Induction of a Th1-like response in vitro
NZ523408A (en) 2000-06-26 2006-02-24 Stressgen Biotechnologies Corp Human papilloma virus treatment
AU2002247084B2 (en) 2001-02-05 2007-01-04 Nventa Biopharmaceuticals Corporation Hepatitis B virus treatment
EP2301566B1 (en) 2002-05-21 2013-07-03 Irun R. Cohen DNA vaccines encoding heat shock proteins
AU2002952492A0 (en) * 2002-11-06 2002-11-21 Cbio Limited Chaperonin 10 immunosuppression
JP2007530420A (en) * 2003-07-07 2007-11-01 ザ・ジェネラル・ホスピタル・コーポレイション fugetactic protein, compositions and methods of use
US7842299B2 (en) 2006-03-14 2010-11-30 Oregon Health & Science University Methods for producing an immune response to tuberculosis
EP2125868B1 (en) 2007-02-28 2015-06-10 The Govt. Of U.S.A. As Represented By The Secretary Of The Department Of Health And Human Services Brachyury polypeptides and methods for use
CA3004867C (en) 2008-06-26 2020-09-15 Orphazyme Aps Use of hsp70 as a regulator of enzymatic activity
US8664183B2 (en) 2009-02-27 2014-03-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services SPANX-B polypeptides and their use
CN102462841A (en) * 2010-11-09 2012-05-23 中国科学院微生物研究所 Method for promoting immunological activity of gp96 protein and application thereof
US9662375B2 (en) 2010-11-30 2017-05-30 Orphazyme Aps Methods for increasing intracellular activity of Hsp70
WO2014043518A1 (en) 2012-09-14 2014-03-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Brachyury protein, non-poxvirus non-yeast vectors encoding brachyury protein, and their use
BR102014002362A8 (en) 2014-01-30 2018-04-17 Uniao Brasileira De Educacao E Assistencia Mantenedora Da Puc Rs method of immunomodulation and / or preservation of ex vivo organs, compositions, process and uses
RU2745292C2 (en) 2014-09-15 2021-03-23 Орпхазиме А/C Composition with arimoclomol
EP4137150A1 (en) 2015-08-03 2023-02-22 The United States of America, as represented by the Secretary, Department of Health and Human Services Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use
US10898476B2 (en) 2016-04-13 2021-01-26 Orphazyme A/S Heat shock proteins and cholesterol homeostasis
CA3021900A1 (en) 2016-04-29 2017-11-02 Orphazyme A/S Arimoclomol for treating glucocerebrosidase associated disorders
MX2023005954A (en) 2020-11-19 2023-09-04 Zevra Denmark As Processes for preparing arimoclomol citrate and intermediates thereof.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891653A (en) * 1995-12-29 1999-04-06 Attfield; Derrick Cecil Method of suppressing graft rejection by means of stress proteins

Also Published As

Publication number Publication date
EP1218030A4 (en) 2004-09-15
WO2001017554A1 (en) 2001-03-15
WO2001017554A9 (en) 2002-09-26
EP1218030A1 (en) 2002-07-03
CA2383213A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
AU7361900A (en) Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
NZ514350A (en) Compositions and methods for effecting the levels of cholesterol
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2002320456A1 (en) Removable stent and method of using the same
ZA989461B (en) Methods and compositions for the treatment of autoimmune disease using heat shock proteins
AU2212299A (en) Compositions and methods for the treatment of tumor
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU9016898A (en) Methods and compositions for treatment of restenosis
AU4136901A (en) Novel methods for the treatment and prevention of dizziness and pruritus
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU1590201A (en) Compositions and methods for treating autoimmune diseases and transplant rejections
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU2002346882A1 (en) Methods for the treatment of osteoarthritis and compositions thereof
AU6786898A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
IL130968A0 (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase